The catalytic cysteine of islet antigen 2 is crucial to autoantibody binding in type 1 diabetes

被引:0
|
作者
Elvers, K. T. [1 ]
Broadhurst, J. W. [1 ]
Easton, P. R. [1 ]
Lampasona, V. [2 ]
Bingley, P. J. [1 ]
Williams, A. J. K. [1 ]
机构
[1] Univ Bristol, Bristol BS8 1TH, Avon, England
[2] Ctr Genom Bioinformat & Biostat, Milan, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
431
引用
收藏
页码:S178 / S179
页数:2
相关论文
共 50 条
  • [21] Loss of Multiple Islet Autoantibody Status during Progression to Type 1 Diabetes
    Simmons, Kimber M.
    Dong, Fran
    Waugh, Kathleen
    Yu, Liping
    Rewers, Marian
    DIABETES, 2024, 73
  • [22] Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes
    Eleni Z. Giannopoulou
    Christiane Winkler
    Ruth Chmiel
    Claudia Matzke
    Marlon Scholz
    Andreas Beyerlein
    Peter Achenbach
    Ezio Bonifacio
    Anette-G. Ziegler
    Diabetologia, 2015, 58 : 2317 - 2323
  • [23] The relationship between islet autoantibody status and the genetic risk of type 1 diabetes in adult-onset type 1 diabetes
    Nicholas J. Thomas
    Helen C. Walkey
    Akaal Kaur
    Shivani Misra
    Nick S. Oliver
    Kevin Colclough
    Michael N. Weedon
    Desmond G. Johnston
    Andrew T. Hattersley
    Kashyap A. Patel
    Diabetologia, 2023, 66 : 310 - 320
  • [24] The relationship between islet autoantibody status and the genetic risk of type 1 diabetes in adult-onset type 1 diabetes
    Thomas, Nicholas J.
    Walkey, Helen C.
    Kaur, Akaal
    Misra, Shivani
    Oliver, Nick S.
    Colclough, Kevin
    Weedon, Michael N.
    Johnston, Desmond G.
    Hattersley, Andrew T.
    Patel, Kashyap A.
    DIABETOLOGIA, 2023, 66 (02) : 310 - 320
  • [25] Islet Cell Autoantibody Reactivity on Pancreatic Tissue from Donors with Type 1 Diabetes
    Rowe, Patrick
    Posgai, Amanda L.
    Campbell-Thompson, Martha
    Wasserfall, Clive
    Martino, Maria Fernanda
    Albanese-O'Neil, Anastasia
    Schatz, Desmond
    Atkinson, Mark
    DIABETES, 2011, 60 : A669 - A669
  • [26] Family Ties and Screening Whys: Decisions in Islet Autoantibody Testing for Type 1 Diabetes
    Hood, K.
    Agardh, D.
    Ebekozien, O.
    Lee, W. -N.
    Melin, J.
    Wieloch, M.
    Sims, E.
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 53 - 53
  • [27] Stratifying risk for onset of type 1 diabetes using islet autoantibody trajectory clustering
    Mistry, Sejal
    Gouripeddi, Ramkiran
    Raman, Vandana
    Facelli, Julio C.
    DIABETOLOGIA, 2023, 66 (03) : 520 - 534
  • [28] Islet Autoantibody Levels Differentiate Progression Trajectories in Individuals With Presymptomatic Type 1 Diabetes
    Kwon, Bum Chul
    Achenbach, Peter
    Anand, Vibha
    Frohnert, Brigitte I.
    Hagopian, William
    Hu, Jianying
    Koski, Eileen
    Lernmark, Ake
    Lou, Olivia
    Martin, Frank
    Ng, Kenney
    Toppari, Jorma
    Veijola, Riitta
    DIABETES, 2022, 71 (12) : 2632 - 2641
  • [29] Alloantibody and Autoantibody Monitoring Predicts Islet Transplantation Outcome in Human Type 1 Diabetes
    Piemonti, Lorenzo
    Everly, Matthew J.
    Maffi, Paola
    Scavini, Marina
    Poli, Francesca
    Nano, Rita
    Cardillo, Massimo
    Melzi, Raffaella
    Mercalli, Alessia
    Sordi, Valeria
    Lampasona, Vito
    de Arias, Alejandro Espadas
    Scalamogna, Mario
    Bosi, Emanuele
    Bonifacio, Ezio
    Secchi, Antonio
    Terasaki, Paul I.
    DIABETES, 2013, 62 (05) : 1656 - 1664
  • [30] Islet autoantibody TypesMark differential clinical characteristics at diagnosis of pediatric type 1 diabetes
    Nieto, Jacob
    Castillo, Beatriz
    Astudillo, Marcela
    Tosur, Mustafa
    Balasubramanyam, Ashok
    Pietropaolo, Massimo
    Redondo, Maria J.
    PEDIATRIC DIABETES, 2021, 22 (06) : 882 - 888